SCHEMBL4975006

SCHEMBL4975006

CNC(C(C)NC(=O)O)[C@H]1CCCOC1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4970041 0.82 MMP2 (0.39) SMN1; SMN2HPGD
SCHEMBL4973787 0.82 SMN1; SMN2 (0.33) PKMSMN1; SMN2GAAHPGD
SCHEMBL4752805 0.82 SMN1; SMN2 (0.33) PKMSMN1; SMN2GAAHPGD
SCHEMBL4971712 0.81 MMP2 (0.41) SMN1; SMN2
SCHEMBL4971492 0.81 MMP2 (0.41) SMN1; SMN2
SCHEMBL4975234 0.81 SMN1; SMN2 (0.32) PKMSMN1; SMN2GAAHPGD
SCHEMBL4972570 0.78 CA12 (0.33) SMN1; SMN2
SCHEMBL4974662 0.78 CA12 (0.33) SMN1; SMN2
SCHEMBL4973637 0.73 MEN1 (0.31)
SCHEMBL4972141 0.72 MAPK1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed